ATYR Deadline: ATYR Investors with Losses in Excess of $100K Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit

When the true details entered the market, the lawsuit claims that investors suffered damages. Accessibility StatementSkip Navigation NEW YORK, Nov. 26, 2025 /PRNewswire/ --Â Why:Â Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased aTyr Pharma common stockÂ during ...